Use of Maytenus Ilicifolia in the Treatment of Dyspepsia
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Lyen an sove nan clipboard la
EstatiSispann
Patwone
Casa Espirita Terra de Ismael
Kolaboratè
University of Sao Paulo
ESÈ KLINIK: NCT01408849
BioSeek: NCT01408849
Mo kle
Abstrè
This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).
Dat
| Dènye verifye: | 06/30/2016 |
| Premye Soumèt: | 07/28/2011 |
| Enskripsyon Estimasyon Soumèt: | 08/01/2011 |
| Premye afiche: | 08/02/2011 |
| Dènye Mizajou Soumèt: | 07/24/2016 |
| Dènye Mizajou afiche: | 07/25/2016 |
| Dat aktyèl kòmanse etid la: | 01/31/2015 |
| Dat Estimasyon Prensipal Estimasyon an: | 12/31/2015 |
| Dat estime fini etid la: | 12/31/2015 |
Kondisyon oswa maladi
Dyspepsia
Entèvansyon / tretman
Drug: Maytenus
Drug: Omeprazole
Faz
Faz 2
Gwoup bra
| Bra | Entèvansyon / tretman |
|---|---|
| Experimental: Maytenus Tea of Martens ilicifolia leaves | Drug: Maytenus 2 g of powdered leaves in 150 mL of boiling water, 3 times a day, for 8 weeks |
| Active Comparator: Omeprazole Omeprazole as active comparator | Drug: Omeprazole Standard therapy |
Kritè kalifikasyon yo
| Laj ki kalifye pou etid | 18 Years Pou 18 Years |
| Sèks ki kalifye pou etid | All |
| Aksepte Volontè Healthy | Wi |
| Kritè | Inclusion Criteria: - age > 18 years - being literate - diagnosis of dyspepsia - initial SODA score > or = 25 Exclusion Criteria: - pregnancy - lactation - allergy to Maytenus species - fail to use the drug for 3 uninterrupted weeks - new onset serious adverse events, attributable to the drug - patient's request |
Rezilta
Mezi Rezilta Prensipal yo
1. SODA score [8 weeks]
Mezi Rezilta Segondè
1. Sydney classification [8 weeks]
